Sonothera
- Biotech or pharma, therapeutic R&D
SonoThera has developed a non-viral, non-invasive ultrasound-mediated gene delivery platform that is redefining genetic medicine. Our platform can precisely target specific organs and tissues without off-targeting, deliver payloads of any format (DNA, RNA, etc.) and any size in a redosable and titratable manner and with excellent safety and tolerability. Our pipeline includes programs in the kidney, liver, muscle, heart and CNS.
Address
South San FranciscoCalifornia
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}